Abiopharma

New Form 8-K - Autolus Therapeutics plc Filed: 2025-08-12 AccNo: 0001730463-25-000064 Size: 4 MB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 10-Q - Aprea Therapeutics, Inc. Filed: 2025-08-12 AccNo: 0001558370-25-011152 Size: 4 MB

New Form 8-K - Taysha Gene Therapies, Inc. Filed: 2025-08-12 AccNo: 0001193125-25-178504 Size: 244 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 10-Q - Coya Therapeutics, Inc. Filed: 2025-08-12 AccNo: 0000950170-25-106934 Size: 7 MB

New Form SC 14D9 - DURECT CORP Filed: 2025-08-12 AccNo: 0001193125-25-178502 Size: 617 KB

Evogene and Professor Ehud Gazit of Tel Aviv University Announce a Collaboration to Develop New Therapeutics for Metabolic Diseases

New Form 8-K - Coya Therapeutics, Inc. Filed: 2025-08-12 AccNo: 0000950170-25-106932 Size: 459 KB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 8-K - Aprea Therapeutics, Inc. Filed: 2025-08-12 AccNo: 0001558370-25-011149 Size: 7 MB Item 2.02: Results of Operations and Financial Condition Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 6-K - Nano-X Imaging Ltd. Filed: 2025-08-12 AccNo: 0001213900-25-074643 Size: 396 KB

New Form 8-K - BioXcel Therapeutics, Inc. Filed: 2025-08-12 AccNo: 0001104659-25-076501 Size: 286 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

Ginkgo Bioworks - Ginkgo Automation AppointsBrian OSullivan as Head of Commercial to Accelerate External Growth

Anixa Biosciences Announces Issuance of Additional U.S. Patent for CAR-T Technology

New Form 6-K - PolyPid Ltd. Filed: 2025-08-12 AccNo: 0001213900-25-074642 Size: 30 KB

Integer Holdings Corporation - Integer to Present at 2025 Wells Fargo Healthcare Conference on Sept. 4

CoyaTherapeutics - Coya Therapeutics Reports Second Quarter Financial Results and Provides a Corporate Update